Patients with loss-of-function mutations in the PTEN gene, a negative regulator of mTOR signaling, are predisposed to developing macrocephaly, autism spectrum disorder (ASD), seizures, and intellectual disability [32]. The gene discussed is MTOR; the disease is Macrocephaly.